Back to Search
LORI MORRISSEY, PHARMD, RPH
PHARMD, RPH
Pharmacist
NPI: 1063491330Individual
Specialties, Licenses & Credentials
Research & Publications (18)
Evaluating preference-sensitive care for uterine fibroids: it's not so simple.
PMID 19580366·J Womens Health (Larchmt)·2009
8-other
Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain.
PMID 19023890·Pediatr Blood Cancer·2009
8-other
Laser-assisted end-to-end BioWeld anastomosis in an ovine model.
PMID 17886280·Lasers Surg Med·2007
7-preclinical
Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial.
PMID 16249353·Oncologist·2005
3-trial
Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network.
PMID 15632411·J Clin Oncol·2005
3-trial
Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial.
PMID 15561808·Oncologist·2004
3-trial
Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial.
PMID 14601089·Cancer·2003
3-trial
Rituximab as first-line and maintenance therapy for patients with indolent non-hodgkin's lymphoma.
PMID 12377971·J Clin Oncol·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- MAYO CLINIC PHARMACY, 200 FIRST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1063491330
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile